Lv1
40 积分 2023-10-03 加入
The Price of Survival: Global Inequities in Anti-GD2 Immunotherapy for Neuroblastoma
1天前
待确认
Cost‐effectiveness analysis of dinutuximab β for the treatment of high‐risk neuroblastoma in China
1天前
已完结
Bi-allelic MED16 variants cause a MEDopathy with intellectual disability, motor delay, and craniofacial, cardiac, and limb malformations
10个月前
已完结
皖公网安备34019202002308
